Purpose: To report the occurrence of epileptic seizures in humans. closely
related to the use of the centrally acting muscle relaxant thiocolchicoside
.
Methods: Description of three case histories.
Results: Two patients, affected with complex-partial seizures. sometimes se
condarily generalized, receiving antiepileptic therapy, were seizure free f
or 7 and 9 years, respectively. They had the reappearance of tonic-clonic s
eizures few days after the continued use of thiocolchicoside, at a cumulati
ve dose of the drug of 52 mg and 76 mg. respectively. The third patient was
brain damaged and without a history of seizures. He had a sudden. convulsi
ve seizure a few minutes after 4 mg intramuscular thiocolchicoside.
Conclusions: Our case histories indicate that thiocolchicoside has a powerf
ul epileptogenic activity. This drug should be avoided in patients with epi
lepsy or acute brain injury and possible disruption of the blood-brain barr
ier.